Thursday afternoon, MVA member FUJIFILM Diosynth Biotechnologies, which is Biotechnologies is a world-leading contract development and manufacturing organization (CDMO) for the biopharmaceutical industry, celebrated its recent production expansion in Denmark. This first expansion for the site increases capacity from six to twelve bioreactors for mammalian cell culture, making the site the largest end-to-end biopharmaceutical manufacturing site in Europe.
“Our activities in Hillerød reflect our commitment to being the leading contract manufacturer globally, or a Partner for Life, as we call it, by supporting our clients and their patients worldwide,” says Christian Houborg, site head and senior vice president for FUJIFILM Diosynth Biotechnologies. “This expansion demonstrates our vision to launch strong production capabilities in the global biopharmaceutical industry, ensuring the timely delivery of critical therapies to those in need worldwide,” says Christian.
“One must tip their hat to FUJIFILM Diosynth Biotechnologies and their impressive journey, of which this expansion is the latest evidence. It is a company that contributes both through their production and growth to Danish society. That is something to celebrate,” says Brian Mikkelsen.
He points out that the latest expansion from FUJIFILM Diosynth Biotechnologies merely emphasizes that the potential for continued growth in the life science industry is indeed present.
“This first expansion of our site in Hillerød sets the stage for future developments, which will also extend to the USA, United Kingdom, and Japan,” said Lars Petersen, president and chief executive officer, FUJIFILM Diosynth Biotechnologies. “By investing in state-of-the-art facilities on both sides of the Atlantic and prioritizing our employees, we are uniquely positioned to meet the needs of our partners and patients.”
“This is just the beginning. With our Partners for Life strategy, we are dedicated to fulfilling our promises and ensuring that our global network supports the production of life-changing medicines that improve patients’ lives,” concluded Petersen.
Among the distinguished guest were H.E Ambassador Uyama Hideki, Minister for Industry, Business and Financial Affairs, Morten Bødskov and Mayor of Hillerød, Kirsten Jensen.